(Q33999696)

30 July 2017

1 reference

title

Heart failure as a metabolic problem (English)

1 reference

30 July 2017

1

Anker SD

1 reference

30 July 2017

Rauchhaus M

2

1 reference

30 July 2017

publication date

1 June 1999

1 reference

European Journal of Heart Failure

30 July 2017

published in

1 reference

30 July 2017

volume

1

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

127-131

1 reference

Congestive cardiac failure: central role of the arterial blood pressure

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Neurohumoral mechanisms involved in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

A placebo-controlled study of growth hormone in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

The expression of TNF alpha by human muscle. Relationship to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

Heart failure: a medical hydra

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Metabolic, functional, and haemodynamic staging for CHF?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Increased resting metabolic rate in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2899%2900006-9

7 January 2021

10.1016/S1388-9842(99)00006-9

Identifiers

DOI

1 reference

30 July 2017

1 reference